Intra-Cellular Therapies Inc
Change company Symbol lookup
Select an option...
ITCI Intra-Cellular Therapies Inc
HUN Huntsman Corp
IART Integra Lifesciences Holdings Corp
R Ryder System Inc
AAPL Apple Inc
IIM Invesco Value Municipal Income Trust
QQQ Invesco QQQ Trust
VZ Verizon Communications Inc
CHTR Charter Communications Inc
SPB Spectrum Brands Holdings Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company provides CAPLYTA (lumateperone) for the treatment of schizophrenia in adults. The CAPLYTA is a prescription medicine used to treat the depressive episodes in adults with bipolar I or II, that can be taken alone or with lithium or valproate. The Company's pipeline is focused on three platforms: lumateperone and follow-on compounds, a phosphodiesterase 1 (PDE1) inhibitor platform and discovery platform which includes ITI-333 a novel compound with high affinity at serotonin 5-HT2A, dopamine D1 and mu opioid (MOP) receptors. The Company’s subsidiaries are ITI, Inc. (ITI) and ITI Limited.

Price
Delayed
$52.47
Day's Change
-1.10 (-2.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
54.20
Day's Low
51.24
Volume
(Below Average)

Today's volume of 705,652 shares is on pace to be lower than ITCI's 10-day average volume of 1,016,423 shares.

705,652
  • Prev Close
    53.57
  • Today's Open
    53.09
  • Day's Range
    51.24-54.20
  • Avg Vol (10-day)
    1.0M
  • Last (time)
    2:52p ET 08/15/22
  • Last (size)
    100
  • 52-Wk Range
    28.45 - 66.00
    LowHigh
  • (08/20/21 - 04/07/22)
    20.50%
  • 57.4%
  • Market Cap
    5.0B
  • Shares Outstanding
    94.4M
  • -3.69
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.2
  • 90.59
  • (% of float 07/29/22)
    3.63

Latest News

August 09, 2022
7:30 am ET
Globe Newswire
August 04, 2022
3:07 pm ET
PR Newswire
August 02, 2022
11:53 am ET
Globe Newswire
August 01, 2022
9:01 am ET
Zacks
July 07, 2022
7:06 am ET
MarketWatch
June 24, 2022
6:19 pm ET
Newsfile
June 18, 2022
3:31 pm ET
Accesswire
June 16, 2022
10:29 am ET
BusinessWire
June 14, 2022
10:52 am ET
MarketWatch
June 13, 2022
8:35 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.